Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Transplanting kidneys from donation after cardiac death donors with acute kidney injury.

Jadlowiec CC, Heilman RL, Smith ML, Khamash HA, Huskey JL, Harbell J, Reddy KS, Moss AA.

Am J Transplant. 2019 Oct 14. doi: 10.1111/ajt.15653. [Epub ahead of print]

PMID:
31612611
2.

Using the virtual crossmatch to allow for safer and more efficient kidney transplantation of highly sensitized patients.

Jaramillo A, Reddy KS, Heilman RL.

Transplantation. 2019 Aug 19. doi: 10.1097/TP.0000000000002925. [Epub ahead of print] No abstract available.

PMID:
31449189
3.

Long-term Outcomes Following Kidney Transplantation From Donors With Acute Kidney Injury.

Heilman RL, Smith ML, Smith BH, Kumar A, Srinivasan A, Huskey JL, Khamash HA, Jadlowiec CC, Mathur AK, Moss AA, Reddy KS.

Transplantation. 2019 Sep;103(9):e263-e272. doi: 10.1097/TP.0000000000002792.

PMID:
31205261
4.

Factors associated with adverse outcomes from cardiovascular events in the kidney transplant population: an analysis of national discharge data, hospital characteristics, and process measures.

Mathur AK, Chang YH, Steidley DE, Heilman RL, Wasif N, Etzioni D, Reddy KS, Moss AA.

BMC Nephrol. 2019 May 28;20(1):190. doi: 10.1186/s12882-019-1390-2.

5.

Patient experience after kidney transplant: a conceptual framework of treatment burden.

Lorenz EC, Egginton JS, Stegall MD, Cheville AL, Heilman RL, Nair SS, Mai ML, Eton DT.

J Patient Rep Outcomes. 2019 Jan 30;3(1):8. doi: 10.1186/s41687-019-0095-4.

6.

Transplant center assessment of the inequity in the kidney transplant process and outcomes for the Indigenous American patients.

Keddis MT, Sharma A, Ilyas M, Zhang N, Khamash H, Leischow SJ, Heilman RL.

PLoS One. 2018 Nov 21;13(11):e0207819. doi: 10.1371/journal.pone.0207819. eCollection 2018.

7.

Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma.

Huskey JL, Heilman RL, Khamash H, Fonseca R.

Transplantation. 2018 Dec;102(12):1994-2001. doi: 10.1097/TP.0000000000002449. Review.

PMID:
30211830
8.

Is Recipient HLA-B51 Status Protective for the Risk of BK Infection After Kidney Transplantation?

Heilman RL, Kaplan B.

Transplantation. 2019 Mar;103(3):461-462. doi: 10.1097/TP.0000000000002377. No abstract available.

PMID:
30048392
9.

Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant.

Friedewald JJ, Kurian SM, Heilman RL, Whisenant TC, Poggio ED, Marsh C, Baliga P, Odim J, Brown MM, Ikle DN, Armstrong BD, Charette JI, Brietigam SS, Sustento-Reodica N, Zhao L, Kandpal M, Salomon DR, Abecassis MM; Clinical Trials in Organ Transplantation 08 (CTOT-08).

Am J Transplant. 2019 Jan;19(1):98-109. doi: 10.1111/ajt.15011. Epub 2018 Aug 31.

10.

Cardiorespiratory Fitness (Peak Oxygen Uptake): Safe and Effective Measure for Cardiovascular Screening Before Kidney Transplant.

Chakkera HA, Angadi SS, Heilman RL, Kaplan B, Scott RL, Bollempalli H, Cha SS, Khamash HA, Huskey JL, Mour GK, Sukumaran Nair S, Singer AL, Reddy KS, Mathur AK, Moss AA, Hewitt WR Jr, Qaqish I, Behmen S, Keddis MT, Unzek S, Steidley DE.

J Am Heart Assoc. 2018 May 31;7(11). pii: e008662. doi: 10.1161/JAHA.118.008662.

11.

On Reporting of the Outcomes from Clinical Trials; a Call to Order.

Heilman RL, Srinivas TR, Kaplan B.

Transplantation. 2018 Dec;102(12):1966-1967. doi: 10.1097/TP.0000000000002279. No abstract available.

PMID:
29762457
12.

Early Conversion to Belatacept in Kidney Transplant Recipients With Low Glomerular Filtration Rate.

Abdelwahab Elhamahmi D, Heilman RL, Smith B, Huskey J, Khamash H, Kaplan B.

Transplantation. 2018 Mar;102(3):478-483. doi: 10.1097/TP.0000000000001985.

PMID:
29077658
13.

Potential Impact of Risk and Loss Aversion on the Process of Accepting Kidneys for Transplantation.

Heilman RL, Green EP, Reddy KS, Moss A, Kaplan B.

Transplantation. 2017 Jul;101(7):1514-1517. doi: 10.1097/TP.0000000000001715. Review.

PMID:
28640014
14.

Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function.

Heilman RL, Smith ML, Smith BH, Qaqish I, Khamash H, Singer AL, Kaplan B, Reddy KS.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2225-2232. Epub 2016 Oct 24.

15.

Increasing the Use of Kidneys From Unconventional and High-Risk Deceased Donors.

Heilman RL, Mathur A, Smith ML, Kaplan B, Reddy KS.

Am J Transplant. 2016 Nov;16(11):3086-3092. doi: 10.1111/ajt.13867. Epub 2016 Jun 14. Review.

16.

Do Patient Assessments of Hospital Quality Correlate With Kidney Transplantation Surgical Outcomes?

Chakrabarti AK, Sheetz KH, Katariya NN, Singer AL, Hewitt WR, Heilman RL, Khamash H, Reddy KS, Moss AA, Mathur AK.

Transplant Proc. 2016 Jul-Aug;48(6):1986-92. doi: 10.1016/j.transproceed.2016.03.038.

PMID:
27569933
17.

Prognostic factors in kidney transplantation in the septuagenarian: a multicenter analysis.

Saucedo-Crespo H, Haakinson DJ, Croome KP, Mai ML, Taner CB, Heilman RL, Gonwa T.

Clin Transplant. 2016 Jul;30(7):828-35. doi: 10.1111/ctr.12756. Epub 2016 Jun 9.

PMID:
27146093
18.

Rapid Resolution of Donor-Derived Glomerular Fibrin Thrombi After Deceased Donor Kidney Transplantation.

Batra RK, Heilman RL, Smith ML, Thomas LF, Khamash HA, Katariya NN, Hewitt WR, Singer AL, Mathur AK, Huskey J, Chakkera HA, Moss A, Reddy KS.

Am J Transplant. 2016 Mar;16(3):1015-20. doi: 10.1111/ajt.13561. Epub 2015 Dec 21.

19.

Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation.

Unzueta A, Valdez R, Chang YH, Desmarteau YM, Heilman RL, Scott RL, Douglas DD, Rakela J.

Ann Hepatol. 2016 Jan-Feb;15(1):33-40.

20.

Glucose homeostasis after simultaneous pancreas and kidney transplantation: a comparison of subjects with C-peptide-positive non-type 1 diabetes mellitus and type 1 diabetes mellitus.

Chakkera HA, Kudva YC, Chang YH, Heilman RL, Singer AL, Mathur AK, Hewitt WR, Khamash HA, Huskey JL, Katariya NN, Moss AA, Behmen S, Reddy KS.

Clin Transplant. 2016 Jan;30(1):52-9. doi: 10.1111/ctr.12658. Epub 2015 Nov 26.

PMID:
26485408
21.

Utilization of Kidneys With Acute Kidney Injury in the Extended Criteria Donor Setting.

Heilman RL, Smith ML, Reddy KS.

Am J Transplant. 2015 Oct;15(10):2783. doi: 10.1111/ajt.13392. Epub 2015 Jul 24. No abstract available.

22.

Transplanting Kidneys from Deceased Donors With Severe Acute Kidney Injury.

Heilman RL, Smith ML, Kurian SM, Huskey J, Batra RK, Chakkera HA, Katariya NN, Khamash H, Moss A, Salomon DR, Reddy KS.

Am J Transplant. 2015 Aug;15(8):2143-51. doi: 10.1111/ajt.13260. Epub 2015 Mar 24.

23.

De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation.

Heilman RL, Nijim A, Desmarteau YM, Khamash H, Pando MJ, Smith ML, Chakkera HA, Huskey J, Valdez R, Reddy KS.

Transplantation. 2014 Dec 27;98(12):1310-5. doi: 10.1097/TP.0000000000000216.

PMID:
24879384
24.

Assessing the efficacy of kidney paired donation--performance of an integrated three-site program.

Li H, Stegall MD, Dean PG, Casey ET, Reddy KS, Khamash HA, Heilman RL, Mai ML, Taner CB, Kosberg CL, Bakken LL, Wozniak EJ, Giles KL, Veal LA, Gandhi MJ, Cosio FG, Prieto M.

Transplantation. 2014 Aug 15;98(3):300-5. doi: 10.1097/TP.0000000000000054.

PMID:
24699400
25.

Left ventricular torsion changes post kidney transplantation.

Deng Y, Pandit A, Heilman RL, Chakkera HA, Mazur MJ, Mookadam F.

J Cardiovasc Ultrasound. 2013 Dec;21(4):171-6. doi: 10.4250/jcu.2013.21.4.171. Epub 2013 Dec 27.

26.

Kidney Transplant Program at the Mayo Clinic in Arizona.

Heilman RL, Khamash HA, Huskey JL, Chakkera HA, Batra RK, Katariya NN, Singer AL, Mathur AK, Moss AA, Reddy KS.

Clin Transpl. 2014:61-8.

PMID:
26281128
27.

Delayed allograft inflammation following alemtuzumab induction for kidney transplantation.

Heilman RL, Khamash HA, Smith ML, Chakkera HA, Moss AA, Reddy KS.

Clin Transplant. 2013 Sep-Oct;27(5):772-80. doi: 10.1111/ctr.12201. Epub 2013 Aug 8.

PMID:
23924146
28.

Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial.

Amer H, Griffin MD, Stegall MD, Cosio FG, Park WD, Kremers WK, Heilman RL, Mazur MJ, Hamawi K, Larson TS, Kumar R.

Am J Transplant. 2013 Jun;13(6):1576-85. doi: 10.1111/ajt.12227. Epub 2013 Apr 19.

29.

Primary percutaneous treatment of transplant ureteral strictures using tandem stents.

Kriegshauser JS, Naidu SG, Heilman RL, Huettl EA, Ferlic EA, Castle EP, Hentz JG.

J Vasc Interv Radiol. 2013 Jun;24(6):874-80. doi: 10.1016/j.jvir.2013.02.019. Epub 2013 Apr 15.

PMID:
23597775
30.

Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation.

Chakkera HA, Chang YH, Bodner JK, Behmen S, Heilman RL, Reddy KS, Mulligan DC, Moss AA, Khamash H, Katariya N, Hewitt WR, Pitta TL, Frassetto LA.

Transplant Proc. 2013 Jan-Feb;45(1):137-41. doi: 10.1016/j.transproceed.2012.10.023.

PMID:
23375287
31.

Desensitization in the era of kidney paired donation: the Mayo Foundation 3-site experience.

Schinstock C, Dean PG, Li H, Casey ET, Reddy KS, Khamash HA, Heilman RL, Mai ML, Taner CB, Kosbergl CL, Bakken LL, Wozniak EJ, Giles KL, Veal LA, Gandhi MJ, Cosio FG, Prieto M, Stegall MD.

Clin Transpl. 2013:235-9.

PMID:
25095513
32.

Laparoscopic bilateral native nephrectomies with simultaneous kidney transplantation.

Martin AD, Mekeel KL, Castle EP, Vaish SS, Martin GL, Moss AA, Mulligan DC, Heilman RL, Reddy KS, Andrews PE.

BJU Int. 2012 Dec;110(11 Pt C):E1003-7. doi: 10.1111/j.1464-410X.2012.11379.x. Epub 2012 Aug 9.

33.

Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance.

Kusne S, Vilchez RA, Zanwar P, Quiroz J, Mazur MJ, Heilman RL, Mulligan D, Butel JS.

J Infect Dis. 2012 Sep 15;206(6):875-80. doi: 10.1093/infdis/jis469. Epub 2012 Jul 16.

34.

Ureteral stricture formation in laparoscopically procured living donor kidney transplantation.

Tyson MD, Castle EP, Andrews PE, Heilman RL, Moss AA, Mulligan DC, Reddy KS.

Can J Urol. 2012 Apr;19(2):6188-92.

PMID:
22512964
35.

Resolution of long-standing necrobiosis lipoidica diabeticorum (NLD) lesion after restoration of euglycemia following successful pancreas after kidney (PAK) transplantation: a case report.

Mazur MJ, Lowney AC, Prigoff J, Heilman RL, Chakkera H, Moss A, Mulligan D, Reddy K, Hamawi K.

Transplant Proc. 2011 Nov;43(9):3296-8. doi: 10.1016/j.transproceed.2011.10.005.

PMID:
22099781
36.

Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal.

Heilman RL, Cortese C, Geiger XJ, Younan K, Wadei HM, Mai ML, Reddy KS, Gonwa TA.

Transplantation. 2012 Jan 15;93(1):47-53. doi: 10.1097/TP.0b013e3182394cb3.

PMID:
22067270
37.

Pretransplant risk score for new-onset diabetes after kidney transplantation.

Chakkera HA, Weil EJ, Swanson CM, Dueck AC, Heilman RL, Reddy KS, Hamawi K, Khamash H, Moss AA, Mulligan DC, Katariya N, Knowler WC.

Diabetes Care. 2011 Oct;34(10):2141-5. doi: 10.2337/dc11-0752.

38.

Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal.

Heilman RL, Younan K, Wadei HM, Mai ML, Reddy KS, Chakkera HA, Gonwa TA.

Transplantation. 2011 Oct 15;92(7):767-73. doi: 10.1097/TP.0b013e31822805d7.

PMID:
21775930
39.

Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.

Jimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK.

Transplantation. 2011 Sep 15;92(5):570-4. doi: 10.1097/TP.0b013e318225db2c.

PMID:
21712755
40.

Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal.

Heilman RL, Nijim S, Chakkera HA, Devarapalli Y, Moss AA, Mulligan DC, Mazur MJ, Hamawi K, Williams JW, Reddy KS.

J Transplant. 2011;2011:583981. doi: 10.1155/2011/583981. Epub 2011 May 15.

41.

Living donor kidney transplantation with multiple renal arteries in the laparoscopic era.

Tyson MD, Castle EP, Ko EY, Andrews PE, Heilman RL, Mekeel KL, Moss AA, Mulligan DC, Reddy KS.

Urology. 2011 May;77(5):1116-21. doi: 10.1016/j.urology.2010.07.503. Epub 2010 Dec 8.

PMID:
21145095
42.

Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus.

Chakkera HA, Bodner JK, Heilman RL, Mulligan DC, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Ray RM, Beck GL, Reddy KS.

Transplant Proc. 2010 Sep;42(7):2650-2. doi: 10.1016/j.transproceed.2010.04.065.

43.

Treatment of hepatitis C in renal transplantation candidates: a single-center experience.

Werner T, Aqel B, Balan V, Byrne T, Carey E, Douglas D, Heilman RL, Rakela J, Mekeel K, Reddy K, Vargas HE.

Transplantation. 2010 Aug 27;90(4):407-11. doi: 10.1097/TP.0b013e3181e72837.

PMID:
20571469
44.

Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus.

Chakkera HA, Knowler WC, Devarapalli Y, Weil EJ, Heilman RL, Dueck A, Mulligan DC, Reddy KS, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Castro JC, Cook CB.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1669-75. doi: 10.2215/CJN.09481209. Epub 2010 Jun 17.

45.

Immunosuppression in simultaneous pancreas-kidney transplantation: progress to date.

Heilman RL, Mazur MJ, Reddy KS.

Drugs. 2010 May 7;70(7):793-804. doi: 10.2165/11535430-000000000-00000. Review.

PMID:
20426494
46.

Successful transplantation of a split crossed fused ectopic kidney into a patient with end-stage renal disease.

Mekeel KL, Daley SM, Andrews PE, Moss AA, Heilman RL, Mazur MJ, Chakkera HA, Hamawi K, Mulligan DC, Sudhakar Reddy K.

J Transplant. 2010;2010:383972. doi: 10.1155/2010/383972. Epub 2010 Mar 25.

47.

Increased prevalence of reduced estimated glomerular filtration rate in chronic hepatitis C patients.

Petre SA, Sachdev MS, Noble BN, Rosati M, Mazur MJ, Heilman RL, Harrison ME, Douglas DD, Balan V.

Dig Dis Sci. 2010 May;55(5):1450-7. doi: 10.1007/s10620-010-1170-0. Epub 2010 Mar 19.

PMID:
20300844
48.

Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients.

Heilman RL, Devarapalli Y, Chakkera HA, Mekeel KL, Moss AA, Mulligan DC, Mazur MJ, Hamawi K, Williams JW, Reddy KS.

Am J Transplant. 2010 Mar;10(3):563-70. doi: 10.1111/j.1600-6143.2009.02966.x. Epub 2010 Feb 1.

49.

Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation.

Chakkera HA, Hanson RL, Raza SM, DiStefano JK, Millis MP, Heilman RL, Mulligan DC, Reddy KS, Mazur MJ, Hamawi K, Moss AA, Mekeel KL, Cerhan JR.

Transplant Proc. 2009 Dec;41(10):4172-7. doi: 10.1016/j.transproceed.2009.08.063.

50.

Deceased donor kidney transplantation from donors with acute renal failure due to rhabdomyolysis.

Mekeel KL, Moss AA, Mulligan DC, Chakkera HA, Hamawi K, Mazur MJ, Heilman RL, Reddy KS.

Am J Transplant. 2009 Jul;9(7):1666-70. doi: 10.1111/j.1600-6143.2009.02663.x. Epub 2009 May 20.

Supplemental Content

Loading ...
Support Center